Bio-Rad Laboratories Price to Book Ratio 2010-2024 | BIO
Historical price to book ratio values for Bio-Rad Laboratories (BIO) over the last 10 years. The current price to book ratio for Bio-Rad Laboratories as of November 21, 2024 is 1.20.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bio-Rad Laboratories Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-20 | 323.69 | 1.21 | |
| 2024-09-30 | 334.58 | $267.46 | 1.25 |
| 2024-06-30 | 273.11 | $240.39 | 1.14 |
| 2024-03-31 | 345.87 | $317.32 | 1.09 |
| 2023-12-31 | 322.89 | $306.50 | 1.05 |
| 2023-09-30 | 358.45 | $288.77 | 1.24 |
| 2023-06-30 | 379.12 | $290.51 | 1.31 |
| 2022-12-31 | 420.49 | $324.88 | 1.29 |
| 2022-09-30 | 417.14 | $283.45 | 1.47 |
| 2022-06-30 | 495.00 | $300.44 | 1.65 |
| 2022-03-31 | 563.23 | $340.09 | 1.66 |
| 2021-12-31 | 755.57 | $457.21 | 1.65 |
| 2023-03-31 | 479.02 | $329.77 | 1.45 |
| 2021-09-30 | 745.95 | $512.48 | 1.46 |
| 2021-06-30 | 644.29 | $389.46 | 1.65 |
| 2021-03-31 | 571.17 | $356.45 | 1.60 |
| 2020-12-31 | 582.94 | $331.05 | 1.76 |
| 2020-09-30 | 515.46 | $295.84 | 1.74 |
| 2020-06-30 | 451.49 | $247.77 | 1.82 |
| 2020-03-31 | 350.56 | $212.27 | 1.65 |
| 2019-12-31 | 370.03 | $192.31 | 1.92 |
| 2019-09-30 | 332.74 | $171.41 | 1.94 |
| 2019-06-30 | 312.59 | $184.12 | 1.70 |
| 2019-03-31 | 305.68 | $163.11 | 1.87 |
| 2018-12-31 | 232.22 | $134.91 | 1.72 |
| 2018-09-30 | 312.99 | $163.55 | 1.91 |
| 2018-06-30 | 288.54 | $155.49 | 1.86 |
| 2018-03-31 | 250.08 | $150.58 | 1.66 |
| 2017-12-31 | 238.67 | $98.38 | 2.43 |
| 2017-09-30 | 222.22 | $95.70 | 2.32 |
| 2017-06-30 | 226.31 | $94.90 | 2.38 |
| 2017-03-31 | 199.34 | $91.45 | 2.18 |
| 2016-12-31 | 182.28 | $87.20 | 2.09 |
| 2016-09-30 | 163.81 | $91.49 | 1.79 |
| 2016-06-30 | 143.02 | $88.86 | 1.61 |
| 2016-03-31 | 136.72 | $86.55 | 1.58 |
| 2015-12-31 | 138.66 | $84.83 | 1.63 |
| 2015-09-30 | 134.31 | $82.91 | 1.62 |
| 2015-06-30 | 150.61 | $80.89 | 1.86 |
| 2015-03-31 | 135.18 | $75.46 | 1.79 |
| 2014-12-31 | 120.56 | $75.17 | 1.60 |
| 2014-09-30 | 113.40 | $75.16 | 1.51 |
| 2014-06-30 | 119.71 | $77.94 | 1.54 |
| 2014-03-31 | 128.12 | $77.47 | 1.65 |
| 2013-12-31 | 123.61 | $75.99 | 1.63 |
| 2013-09-30 | 117.56 | $74.10 | 1.59 |
| 2013-06-30 | 112.20 | $72.44 | 1.55 |
| 2013-03-31 | 126.00 | $71.21 | 1.77 |
| 2012-12-31 | 105.05 | $70.77 | 1.48 |
| 2012-09-30 | 106.72 | $68.23 | 1.56 |
| 2012-06-30 | 100.01 | $65.46 | 1.53 |
| 2012-03-31 | 103.69 | $65.15 | 1.59 |
| 2011-12-31 | 96.04 | $61.89 | 1.55 |
| 2011-09-30 | 90.77 | $60.23 | 1.51 |
| 2011-06-30 | 119.36 | $61.51 | 1.94 |
| 2011-03-31 | 120.14 | $57.63 | 2.08 |
| 2010-12-31 | 103.85 | $55.31 | 1.88 |
| 2010-09-30 | 90.51 | $51.38 | 1.76 |
| 2010-06-30 | 86.49 | $47.08 | 1.84 |
| 2010-03-31 | 103.52 | $47.14 | 2.20 |
| 2009-12-31 | 96.46 | $46.47 | 2.08 |
| 2009-09-30 | 91.88 | $44.68 | 2.06 |
| 2009-06-30 | 75.48 | $41.14 | 1.83 |
| 2009-03-31 | 65.90 | $38.68 | 1.70 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $8.977B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |